How big is Option Care Health, Inc.?

As of Jun 18, Option Care Health, Inc. has a market capitalization of $5.23 billion, with recent net sales of $5.19 billion and a net profit of $213.77 million.

Market Cap: As of Jun 18, Option Care Health, Inc. has a market capitalization of 5,225.93 million, categorizing it as a Mid Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the company reported net sales of 5,185.13 million and a net profit of 213.77 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the shareholder's funds amounted to 1,404.24 million, while total assets were reported at 3,525.81 million.

What does Option Care Health, Inc. do?

Option Care Health, Inc. provides home and alternate site infusion services in the U.S. with recent net sales of $1.33 billion and a market cap of approximately $5.23 billion.

Overview:<BR>Option Care Health, Inc. provides home and alternate site infusion services in the United States, operating within the Pharmaceuticals & Biotechnology industry and classified as a mid-cap company.<BR><BR>Financial Snapshot:<BR>- Most recent Net Sales: 1,333 Million (Quarterly Results - Mar 2025)<BR>- Most recent Net Profit: 47 Million (Quarterly Results - Mar 2025)<BR>- Market-cap: USD 5,225.93 Million (Mid Cap)<BR><BR>Key Metrics:<BR>- P/E: 25.00<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.71<BR>- Return on Equity: 15.26%<BR>- Price to Book: 3.87<BR><BR>Contact Details:<BR>- Address: 3000 Lakeside Dr Ste 300N, BANNOCKBURN IL: 60015-5405<BR>- Tel: 1 312 9402443<BR>- Website: https://optioncarehealth.com/

Should I buy, sell or hold Option Care Health, Inc.?

Who are in the management team of Option Care Health, Inc.?

As of March 2022, the management team of Option Care Health, Inc. includes Harry Jansen Kraemer (Independent Non-Executive Chairman), John Rademacher (CEO and Director), and Directors Elizabeth Betten, Alan Nielsen, Timothy Sullivan, and Mark Vainisi. They are responsible for the company's strategic direction and operations.

As of March 2022, the management team of Option Care Health, Inc. includes the following individuals:<BR><BR>- Mr. Harry Jansen Kraemer, who serves as the Independent Non-Executive Chairman of the Board.<BR>- Mr. John Rademacher, who is the Chief Executive Officer and a Director.<BR>- Ms. Elizabeth Betten, who is a Director.<BR>- Mr. Alan Nielsen, who is also a Director.<BR>- Mr. Timothy Sullivan, who serves as a Director.<BR>- Mr. Mark Vainisi, who is a Director.<BR><BR>This team plays a crucial role in guiding the company's strategic direction and operations.

Is Option Care Health, Inc. overvalued or undervalued?

As of October 17, 2025, Option Care Health, Inc. is fairly valued with a P/E ratio of 25 and has shown a year-to-date return of 19.70%, although it has underperformed the S&P 500's 14.08% return over the past year.

As of 17 October 2025, the valuation grade for Option Care Health, Inc. has moved from expensive to fair. The company appears to be fairly valued based on its current metrics, including a P/E ratio of 25, an EV to EBITDA of 15.63, and a Price to Book Value of 3.88. In comparison to peers, Encompass Health Corp. has a more attractive P/E of 20.94, while The Ensign Group, Inc. has a higher P/E of 32.46, indicating that Option Care Health is positioned reasonably within its industry.<BR><BR>While the stock has shown a strong performance year-to-date with a return of 19.70%, it has underperformed the S&P 500 over the past year, which returned 14.08%. This suggests that while the company is fairly valued, there may be room for improvement in its market performance relative to broader market indices. Overall, Option Care Health, Inc. is fairly valued based on the current data.

Is Option Care Health, Inc. technically bullish or bearish?

As of October 31, 2025, Option Care Health, Inc. is in a bearish trend with weak strength indicators, having underperformed the S&P 500 recently and over the long term.

As of 31 October 2025, the technical trend for Option Care Health, Inc. has changed from mildly bearish to bearish. The current stance is bearish with a weak strength indicated by the weekly and monthly MACD being bearish, daily moving averages also bearish, and Bollinger Bands showing a mildly bearish signal. The KST is bearish on the weekly but bullish on the monthly, indicating mixed signals. The stock has underperformed the S&P 500 over the past week and month, with returns of -2.91% and -1.71% compared to the S&P 500's gains of 0.71% and 1.92%, respectively. Over the longer term, the stock has lagged significantly behind the S&P 500, particularly over the 3-year and 5-year periods.